Neuromuscular Adaptations to Exercise In Patients With Type 2 Diabetes Mellitus
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Gait, Unsteady
- Sponsor
- Pamukkale University
- Enrollment
- 72
- Locations
- 1
- Primary Endpoint
- walking speed
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The aim of this study is to compare the effects of high intensity interval exercise and moderate intensity continuous exercise on basic gait parameters in patients with type 2 diabetes mellitus.
Detailed Description
Volunteers with type 2 diabetes mellitus will be evaluated in terms of any contra-indication that will restrain them from making exercise. 90 male or female volunteers who are suitable in terms of inclusion/exclusion criteria will be invited for the study. Volunteers will be randomly distributed to one of the 3 groups. Each group will contain 30 participants. 1. group will make aerobic exercise which is in the form of high intensity interval exercise 2.group will make aerobic exercise which is in the form of moderate intensity continuous exercise 3. Control group. Exercise groups will be cycling under observation in the hospital setting. Control group will make simple stretching exercises at home. Participants will be requested to complete a 3 months of exercise. They will be evaluated before and at the end of the 3 months of exercise with basic gait parameters such as cadence, gait speed, stride length, percentages of swing phase and stance phase evaluated by a wireless digital miniature gait analysis system.
Investigators
GULIN FINDIKOGLU
Associate Professor
Pamukkale University
Eligibility Criteria
Inclusion Criteria
- •Participants must have type 2 Diabetes mellitus less than 10 years and more than 1 year.
- •Participants must have appropriate medical therapy and diet.
- •Participants must not be treated with insulin.
- •Participants must be exercising less than 210 minutes/ week
Exclusion Criteria
- •Participants with prominent cardiovascular disease
- •Participants with coronary artery disease
- •Participants with moderate to severe valvular disease
- •Participants with atrial fibrillation
- •Participants with untreated hypertension
- •Participants with congenital heart disease
- •Participants with retinopathy
- •Participants with neuropathy
- •Participants with macro albuminuria
- •Participants with cerebrovascular disease
Outcomes
Primary Outcomes
walking speed
Time Frame: 12 weeks
change in walking speed in m/s